(Q46405183)

21 December 2017

title

Effect of KMD-3213, an alpha 1a-adrenoceptor-selective antagonist, on the contractions of rabbit prostate and rabbit and rat aorta (English)

1 reference

21 December 2017

author name string

R Yamagishi

1

1 reference

21 December 2017

K Akiyama

2

1 reference

21 December 2017

S Nakamura

3

1 reference

21 December 2017

M Hora

4

1 reference

21 December 2017

N Masuda

5

1 reference

21 December 2017

A Matsuzawa

6

1 reference

21 December 2017

S Murata

7

1 reference

21 December 2017

A Ujiie

8

1 reference

21 December 2017

Y Kurashina

9

1 reference

21 December 2017

K Iizuka

10

1 reference

21 December 2017

M Kitazawa

11

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

21 December 2017

European Journal of Pharmacology

published in

1 reference

21 December 2017

volume

315

1 reference

21 December 2017

issue

1

1 reference

21 December 2017

page(s)

73-79

1 reference

21 December 2017

Alpha 1-adrenoceptor-induced contractility in rat aorta is mediated by the alpha 1D subtype

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

Quantification of alpha 1-adrenoceptor subtypes in human tissues by competitive RT-PCR analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

Use of recombinant alpha 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

Alpha 1-adrenoceptor classification: sharpening Occam's razor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

Pharmacological evidence of distinct alpha 1-adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

Cloning, functional expression and tissue distribution of human cDNA for the alpha 1C-adrenergic receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

alpha 1-Adrenoceptor subtype mediating contraction of the smooth muscle in the lower urinary tract and prostate of rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

Studies on YM-12617: a selective and potent antagonist of postsynaptic alpha 1-adrenoceptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

Benign prostatic hyperplasia. Current pharmacological treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

Use of an alpha 1-blocker, YM617, in the treatment of benign prostatic hypertrophy. YM617 Clinical Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

Characterization of an α1D‐adrenoceptor mediating the contractile response of rat aorta to noradrenaline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

Alpha 1 adrenoceptor subtypes in the human prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

Noradrenaline contractions of human prostate mediated by alpha 1A-(alpha 1c-) adrenoceptor subtype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

Further evidence that the classical alpha 1A- and cloned alpha 1c-adrenoceptors are the same subtype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

Identification, quantification, and localization of mRNA for three distinct alpha 1 adrenergic receptor subtypes in human prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

Difference in mode of action of alpha 1-adrenoceptor antagonists on some vascular smooth muscles and efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

Differences in alpha 1-adrenoceptor mechanisms for phenylephrine and tizanidine in rabbit thoracic aorta and common iliac artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

Characterization of alpha 1-adrenoceptor subtypes in prostate and prostatic urethra of rat, rabbit, dog and man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

The alpha 1d-adrenoceptor subtype is involved in the noradrenaline-induced contractions of rat aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

Cloning, expression and characterization of human alpha adrenergic receptors alpha 1a, alpha 1b and alpha 1c.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

Comparative study on alpha 1-adrenoceptor antagonist binding in human prostate and aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

Alpha 1-adrenoceptor subtype in the rat prostate is preferentially the alpha 1A type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900589-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(96)00589-4

1 reference

21 December 2017

1 reference

21 December 2017